
Xcell Biosciences
Developer of a bench-top primary cell control system designed to advance immunotherapy research and manufacturing, empowering scientists with better tools for cell maintenance, expansion, and control....
Valuation
$0
Share Price
N/A
Total Raised
$60.4M
Last Round
N/A